摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3S,4R)-3,4-bis[(4-methoxyphenyl)methoxy]-4-(2-methylpyrazolo[1,5-a]pyrimidin-6-yl)-1-trityloxy-butan-2-ol | 1442680-13-8

中文名称
——
中文别名
——
英文名称
(2R,3S,4R)-3,4-bis[(4-methoxyphenyl)methoxy]-4-(2-methylpyrazolo[1,5-a]pyrimidin-6-yl)-1-trityloxy-butan-2-ol
英文别名
(2R,3S,4R)-3,4-bis[(4-methoxyphenyl)methoxy]-4-(2-methylpyrazolo[1,5-a]pyrimidin-6-yl)-1-trityloxybutan-2-ol
(2R,3S,4R)-3,4-bis[(4-methoxyphenyl)methoxy]-4-(2-methylpyrazolo[1,5-a]pyrimidin-6-yl)-1-trityloxy-butan-2-ol化学式
CAS
1442680-13-8
化学式
C46H45N3O6
mdl
——
分子量
735.88
InChiKey
KBIWTJHWLCYIFS-DIMVBODBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.2
  • 重原子数:
    55
  • 可旋转键数:
    17
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    96.6
  • 氢给体数:
    1
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of Carbohybrid-Based 2-Aminopyrimidine Analogues As a New Class of Rapid-Acting Antimalarial Agents Using Image-Based Cytological Profiling Assay
    摘要:
    New antimalarial agents that exhibit multistage activities against drug-resistant strains of malaria parasites represent good starting points for developing next-generation antimalarial therapies. To facilitate the progression of such agents into the development phase, we developed an image-based parasitological screening method for defining drug effects on different asexual life cycle stages of Plasmodium falciparum. High-throughput screening of a newly assembled diversity-oriented synthetic library using this approach led to the identification of carbohybrid-based 2-aminopyrimidine compounds with fast-acting growth inhibitory activities against three laboratory strains of multidrug-resistant P. falciparum. Our structure-activity relationship study led to the identification of two derivatives (8aA and 11aA) as the most promising antimalarial candidates (mean EC50 of 0.130 and 0.096 mu M against all three P. falciparum strains, selectivity indices >600, microsomal stabilities >80%, and mouse malaria ED50 values of 0.32 and 0.12 mg/kg/day, respectively), targeting all major blood stages of multidrug-resistant P. falciparum parasites
    DOI:
    10.1021/jm5009693
  • 作为产物:
    参考文献:
    名称:
    Discovery of Carbohybrid-Based 2-Aminopyrimidine Analogues As a New Class of Rapid-Acting Antimalarial Agents Using Image-Based Cytological Profiling Assay
    摘要:
    New antimalarial agents that exhibit multistage activities against drug-resistant strains of malaria parasites represent good starting points for developing next-generation antimalarial therapies. To facilitate the progression of such agents into the development phase, we developed an image-based parasitological screening method for defining drug effects on different asexual life cycle stages of Plasmodium falciparum. High-throughput screening of a newly assembled diversity-oriented synthetic library using this approach led to the identification of carbohybrid-based 2-aminopyrimidine compounds with fast-acting growth inhibitory activities against three laboratory strains of multidrug-resistant P. falciparum. Our structure-activity relationship study led to the identification of two derivatives (8aA and 11aA) as the most promising antimalarial candidates (mean EC50 of 0.130 and 0.096 mu M against all three P. falciparum strains, selectivity indices >600, microsomal stabilities >80%, and mouse malaria ED50 values of 0.32 and 0.12 mg/kg/day, respectively), targeting all major blood stages of multidrug-resistant P. falciparum parasites
    DOI:
    10.1021/jm5009693
点击查看最新优质反应信息

文献信息

  • Synthesis of Molecular Frameworks Containing Two Distinct Heterocycles Connected in a Single Molecule with Enhanced Three-Dimensional Shape Diversity
    作者:Donghyun Lim、Seung Bum Park
    DOI:10.1002/chem.201204293
    日期:2013.5.27
    report the synthesis of fused‐triazole scaffolds that are connected by pyrimidines, pyrazoles, or pyrazolopyrimidines through carbohydrate‐derived stereodivergent linkers. Pyrimidine‐, pyrazole‐, or pyrazolopyrimidine‐based carbohybrids were constructed through condensations of the key intermediates, 2‐C‐formyl glycals, with various dinucleophiles. Fused‐triazole scaffolds were obtained through intramolecular
    在本文中,我们报道了通过糖衍生的立体发散性连接子通过嘧啶吡唑吡唑嘧啶连接的稠合三唑支架的合成。嘧啶吡唑吡唑嘧啶的碳杂物是通过关键中间体2- C-甲酰基缩醛与各种二亲核试剂的缩合反应构建的。使用S N通过叠氮化物炔烃官能团将羰基杂化多元醇部分选择性官能化后,通过分子内1,3-偶极环加成获得熔融三唑支架2型烷基化或Mitsunobu反应。总的来说,这种合成方法在单个分子中提供了两个截然不同的优先亚结构,这些亚结构由衍生自丰富自然手性来源(即碳水化合物)的立体发散性二醇连接基连接。接头中生成的邻位二醇经过进一步修饰,以在两个特权结构之间实现独特的连接性,从而实现了最大的三维形状多样性,我们将其称为接头多样化策略。
  • 피리미딘, 피라졸 및 피라졸로피리미딘 융합된 카보하이브리드 헤테로고리 화합물 라이브러리 및 이의 제조방법
    申请人:Seoul National University R&DB Foundation 서울대학교산학협력단(120070509242) Corp. No ▼ 114371-0009224BRN ▼119-82-03684
    公开号:KR101595939B1
    公开(公告)日:2016-02-19
    본 발명은 카보하이브리드 기반의 분자 골격에 피리미딘, 피라졸 및 피라졸로피리미딘이 융합된 카보하이브리드 헤테로고리 화합물 라이브러리에 관한 것이다.
    本发明涉及基于卡波混合物分子骨架的嘧啶吡唑吡唑嘧啶融合的卡波混合物杂环化合物库。
查看更多

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 重氮四苯基乙烷 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲醇,2-氨基-5-氯-a-乙烯基-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲酸,3-[[2-[[(1,1-二甲基乙氧基)羰基]氨基]-3-[(三苯代甲基)硫代]丙基]氨基]-,(R)- 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 苄基 2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷 芴甲氧羰基-4-叔丁酯-天冬酰胺-S-三氯苯甲基-L-半胱氨酸 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磺基琥珀酰亚胺基-4-[2-(4,4-二甲氧基三苯甲基)]丁酸酯 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-6-O-三苯甲基-beta-D-吡喃半乳糖苷 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷